arrow
S

Satoshi Kano

Faculty of Medicine and Graduate School of Medicine
H指数:28
被引数:2,622

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment and prognosis of subglottic cancers: a 10-year, multicenter, retrospective study in northern Japan

声门下癌的治疗与预后:日本北部10年、多中心回顾性研究

2026-05-210
OAAI
Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial

高风险头颈癌术后放化疗相关吸入性肺炎的危险因素:JCOG1008期II/III临床试验的补充分析

2026-04-180
PRE
Summary of Japanese clinical practice guidelines for head and neck cancer-2025 update edited by the Japan Society for Head and Neck Cancer
2025-10-010
PRE
Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan

不可切除唾液腺癌根治性放射治疗的疗效:一项日本北部多中心回顾性研究

2025-09-010
PRE
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy

HER2-Low表达在涎腺导管癌中的影响:临床病理特征、生存结局及其与雄激素受体靶向治疗的关联

2025-06-010
PRE
Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study

复发或转移性头颈癌在铂类和nivolumab治疗失败后的临床结局:一项多中心回顾性研究

2025-03-310
OA
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)

通过综合分析头颈癌患者的预处理血浆外泌体mrna,鉴定生物标志物以预测nivolumab的治疗反应的全国多中心前瞻性研究 (BIONEXT研究)

2025-01-100
OAAI
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma

头颈部鳞状细胞癌中nivolumab反应的临床,基因组和免疫微环境决定因素

2024-07-291
OAAI
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma

涎腺导管癌自主神经的临床病理及预后意义

2024-07-230
PRE
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU

阿帕鲁胺和戈舍瑞林治疗雄激素受体阳性唾液腺癌: 一项II期非随机临床试验,YATAGARASU

2024-06-280
PRE
Clinical outcomes for olfactory neuroblastoma
2024-05-020
OAAI
Prognostic scores for patients with salivary adenoid cystic carcinoma without lymph node metastasis
2023-10-013
OAAI
The Landscape of MYB/MYBL1-and Peri-MYB/MYBL1-Associated Rearrangements in Adenoid Cystic Carcinoma

腺样囊性癌中MYB/MYBL1-and周围MYB/MYBL1-Associated重排的景观

2023-10-0110
PRE
Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinoma

肿瘤免疫微环境在涎腺导管癌中的预后价值及临床病理作用

2023-07-194
PRE